Beta Titanium Surface Function Now Comes With a Load Ceiling
A study published in Friction on 2026-08-17 combined bulk aging with a catalytic ceramic conversion treatment on the metastable β-titanium alloy Ti-15V-3Al-3Cr-3Sn (Ti-15-3), and reported that both the treated surface and the underlying metal improved at the same time. Tensile strength rose from 872 ± 39 MPa to 1,280 ± 40 MPa — roughly 50% — while the treated surface gained hardness, wear resistance and, in one variant, antibacterial activity (paper).
The result that matters for buyers is not “harder surface, stronger part.” It is that the two catalyst routes tested did not deliver the same surface. One route carried load; the other killed bacteria. Choosing between them is a purchasing decision made before the part is made, not a coating specified after it.

The Treatment Is Coupled to Bulk Heat Treatment, Not Added After It
The authors call the approach integrated bulk heat treatment with surface functionalisation (IBTSF). Bulk aging and the catalytic ceramic conversion treatment (C3T), catalysed with either Ag or Au, run as one integrated route rather than as a heat treatment followed by a separate surface step.
That coupling is the whole point, and it is what separates this from a coating. A conventional surface layer is applied to a part whose bulk properties are already fixed; the surface can be specified, quoted and changed independently. Here the thermal exposure that builds the surface is the same thermal exposure that ages the metastable β structure. Both reported variants ended at 1,280 ± 40 MPa — the surface treatment did not cost bulk strength, because it was never a separate step competing for thermal budget.
The practical consequence runs the other way as well. If the surface route changes, the bulk condition changes with it. A supplier cannot swap the catalyst, or drop the conversion treatment, and hand back a part whose mechanical certificate still applies.
Gold Carried Load, Silver Carried Antibacterial Duty
This is where the two routes separate, and the separation is sharp.
The Au-catalysed treatment reached near-zero wear at 20 N with a low, stable coefficient of friction of about 0.3, which the authors attribute to a lubricating tribo-film forming during sliding.
The Ag-catalysed treatment held stable tribological performance only up to 10 N. What it delivered instead was passive Ag-ion release and antibacterial efficacy of 99.878% against E. coli and 99.999% against S. aureus within 3-6 hours of contact.
So the same process family, differing only in catalyst, produced a 2× difference in the load at which tribological behaviour stayed stable. For a component that sees real contact stress, that is not a feature list item — it is the ceiling. And the abstract does not report the Au route’s antibacterial performance or the Ag route’s behaviour at 20 N, so the trade-off should be read as reported rather than assumed to be symmetric.
A buyer who specifies “multifunctional surface” without naming the service contact load has not specified anything. Two parts can both satisfy that phrase and fail differently.

What These Numbers Cannot Be Used For
The tribological values come from laboratory loading, not from service. Near-zero wear at 20 N in a controlled test says nothing about wear life under real contact geometry, counterface material, debris, lubrication state or duty cycle. It is a comparison between two treatments, not a service-life prediction.
The antibacterial figures are in-vitro contact results over 3-6 hours. They are not infection rates, not implant outcomes, and not evidence about how long passive Ag-ion release continues once the reservoir depletes. Anyone converting 99.999% into a clinical claim is going well past what the work supports.
The alloy boundary is equally hard. One metastable β alloy was tested. Ti-15-3 ages differently from other β alloys and very differently from α+β grades such as Ti-6Al-4V, so neither the strength gain nor the load ceiling transfers by analogy.
And the economics are simply absent. The catalysts are precious metals. The study reports no cost, no batch-to-batch consistency data and no scale-up assessment, which means the route’s industrial feasibility is an open question rather than a demonstrated one.
A Six-Line Coupling Window for Beta Titanium Surfaces
| Control line | Question to answer before release | Evidence to retain |
|---|---|---|
| Function target | Which surface function is actually required — wear, antibacterial, or both? | Written requirement naming the function, not a hardness value alone |
| Catalyst route and load ceiling | Which catalyst, and what contact load did it qualify to? | Treatment record plus the loading condition behind the accepted result |
| Bulk coupling | Which aging condition is embedded in this surface route? | Combined thermal record and bulk mechanical test on the same route |
| Contact and service conditions | Counterface, geometry, duty cycle, environment, expected life | Service condition statement agreed before the process is fixed |
| Evidence type | Laboratory comparison, qualification test, or service data? | Test method, load, duration and what each result does not cover |
| Change and acceptance authority | Which deviation reopens bulk qualification? | Approved change notice and the party authorised to release |
For suppliers of titanium bar and precision-machined titanium components, the line that gets skipped most often is the third one. Surface treatment is usually quoted as a finishing operation with its own lead time and its own certificate. In an integrated route it is neither — it is part of the metallurgical condition, and the mechanical certificate belongs to the combination.
The useful reading of this work is narrow and worth keeping narrow. A single integrated route lifted bulk strength by about 50% while adding surface function, which is genuinely a better trade than the usual one. But it also showed that within that route, the catalyst decides whether the part is a wear component or an antibacterial one. Specify the service load and the required function first; treat hardness as a result of that decision rather than a substitute for it.
FAQ
# What did the Ti-15-3 study actually test?
# Why does the catalyst change the load at which the surface stays stable?
# Does adding surface function reduce bulk strength?
# Can the antibacterial percentages be read as clinical performance?
Need this material? Get a factory-direct quote.